Due to the limited number of patients whose tumors had PD-L1 expression ≥ 5%, the researchers attempted to use PD-L1 expression of tumor cells (TCs)/immune cells (ICs) at 1% and 5% as cut-off values to analyze the effect of PD-L1 expression on survival. The gene discussed is CD274; the disease is neoplasm.